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Available online 10 November 2016This cross-sectional study investigated the correlation between the CAG repeat length and the degeneration of
cerebellum in spinocerebellar ataxia type 3 (SCA3) patients based on neuroimaging approaches. Forty SCA3 pa-
tients were recruited and classiﬁed into two subgroups according to their CAG repeat lengths (≥74 and b74).We
measured each patient's Scale for the Assessment and Rating of Ataxia (SARA) score, N-acetylaspartate (NAA)/
creatine (Cr) ratios based on magnetic resonance spectroscopy (MRS), and 3-dimensional fractal dimension
(3D-FD) values derived from magnetic resonance imaging (MRI) results. Furthermore, the 3D-FD values were
used to construct structural covariance networks based on graph theoretical analysis. The results revealed that
SCA3 patients with a longer CAG repeat length demonstrated earlier disease onset. However, the CAG repeat
length did not signiﬁcantly correlate with their SARA scores, cerebellar NAA/Cr ratios or cerebellar 3D-FD values.
Network dissociation between cerebellar regions and parietal-occipital regions was found in SCA3 patients with
CAG ≥ 74, but not in those with CAG b 74. In conclusion, the CAG repeat length is uncorrelatedwith the change of
SARA score, cerebellar function and cerebellar structure in SCA3. Nevertheless, a longer CAG repeat length may
indicate early structural covariance network dissociation.








Spinocerebellar ataxia type 3 (SCA3), also referred to as
Machado–Joseph disease, is an autosomal dominant neurodegenera-
tive disorder (do Carmo Costa and Paulson, 2012). Progressive atax-
ia, external ophthalmoplegia, dysarthria, dysphagia, pyramidal signs,
dystonia, and rigidity are common clinical features of SCA3 (do
Carmo Costa and Paulson, 2012), and some patients also manifest
extracerebellar pathologies, such as spinal cord affections, peripher-
al polyneuropathy and basal ganglia disease (Pedroso et al., 2013).
The cerebellum is one of the well-known regions mainly affected in
SCA3 patients. Especially, cerebellar nuclei are primarily affected at
the beginning of the disease. Many neuropathology studies (Durr et
al., 1996; Koeppen, 2005; Scherzed et al., 2012; Takiyama et al.,
1994) have reported atrophy or neuronal loss in the cerebellargy, Taipei Municipal Gan-Dau
. This is an open access article undercortex, vermis, peduncles, and deep nuclei. Structural or functional
degeneration of the cerebellum can be observed by different neuro-
imaging approaches including magnetic resonance imaging (MRI)
volumetry (Eichler et al., 2011; Klockgether et al., 1998b; Reetz et
al., 2013; Schulz et al., 2010; Stefanescu et al., 2015), diffusion tensor
imaging (DTI) (Guimaraes et al., 2013), magnetic resonance spec-
troscopy (MRS) (Adanyeguh et al., 2015; Lirng et al., 2012; Wang et
al., 2012), and position emission tomography (Wang et al., 2007).
Some studies have reported that SCA3 may be caused by abnormal
CAG repeat expansion in the coding region of chromosome 14q32.1
(Kawaguchi et al., 1994; Takiyama et al., 1994). The CAG repeat length
substantially affects the clinical characteristics of SCA3 patients (do
Carmo Costa and Paulson, 2012). For example, in healthy subjects, the
CAG repeat length in the gene should be shorter than 44; a CAG repeat
length longer than 60 may lead to the manifestation of clinical symp-
toms in SCA3 patients (do Carmo Costa and Paulson, 2012). Moreover,
SCA3 patients with a longer CAG repeat length may exhibit more
rapid progression through disease stages (Klockgether et al., 1998a).
The CAG repeat length is also negatively correlated with the age of
onset (AO) of SCA3 patients (Durr et al., 1996; Maciel et al., 1995).the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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ered to possibly exhibit more rapid disease progression, subsequently
leading to earlier disease onset. A more rapid disease progression can
partly, if not wholly, be ascribed to more rapid cerebellar degeneration,
because the cerebellum is themajor disease-involved region in SCA3. To
date, it has been speculated that there is a correlation between the CAG
repeat length and the cerebellar degeneration of SCA3 patients. Howev-
er, reports with positive and negative evidence make the inference in-
conclusive (D'Abreu et al., 2012; Eichler et al., 2011; Klockgether et al.,
1998b; Onodera et al., 1998; Reetz et al., 2013; Schulz et al., 2010;
Stefanescu et al., 2015).
This study comprehensively investigated the mechanisms by which
the CAG repeat length inﬂuences the cerebellar degeneration of SCA3
patients from 3 different perspectives, namely cerebellar function, cere-
bellar structure, and cerebellar structural network based on MRS and
MRI. The N-acetylaspartate (NAA) concentration is considered an indi-
cator of neuronal integrity (Bachelard and Badar-Goffer, 1993). There-
fore, the NAA concentration measured by MRS can serve as a
functional probe for cerebellar dysfunction. Our previous study (Wang
et al., 2012) has reported that the ratios of NAA to creatine (Cr) in the
right cerebellum (Rt-Cb-NAA), left cerebellum (Lt-Cb-NAA), and vermis
(V-NAA) were signiﬁcantly lower in SCA3 patients than in controls, and
these ratios were closely correlated with the score of Scale for the as-
sessment and rating of ataxia (SARA) (Schmitz-Hübsch et al., 2006). In
contrast to the NAA measurement, the three-dimensional fractal di-
mension (3D-FD) method is an efﬁcient quantiﬁer for cortical folding
complexity assessment, and 3D-FD is effective for studying themorpho-
logical change in the cortical structure caused by various neurological
disorders based on MRI images (Ha et al., 2005; King et al., 2010;
Sandu et al., 2008; Thompson et al., 2005). Our previous studies have
applied this method to detect brain atrophy in multiple system atrophy
of the cerebellar type (Wu et al., 2010) and SCA3 (Wang et al., 2015).
Complementary to measuring the impairment of the cerebellar
function and structure based on the NAA and 3D–FD, graphic-based
brain network analysis can be used to analyse the destruction or
reorganisation of brain networks caused by neurological diseases
(Braun et al., 2009; Rubinov and Sporns, 2010). The brain network is
constructed by a collection of nodes and links, in which the nodes rep-
resent brain regions and the links represent connections between
paired brain regions. These connections can be structural, functional,
or effective depending on the type of data set (Friston, 1994). Recently,
many studies (Alexander-Bloch et al., 2013; Evans, 2013) have investi-
gated brain networks constructed based on the structural covariance
between brain regions across a group of subjects. Such structural covari-
ance networks showed similarity with the results of DTI tractography
(Gong et al., 2012; Lerch et al., 2006) and functional MRI (fMRI)
(Wang et al., 2014). These results provided the motivational basis for
us to use the morphometric index of 3D-FD to establish the structural
brain network of SCA3 patients.
In this study,we hypothesised that the CAG repeat length is correlat-
ed with the change of cerebellar function and structure in SCA3. We
used NAA/Cr ratios and 3D-FD values to investigate the inﬂuence of
the CAG repeat length on the cerebellar function and structure of
SCA3 patients. Furthermore, graphic-based brain network analysis was
performed to determinewhether the CAG repeat length affects the net-
work between the cerebellum and other brain regions.
2. Materials and methods
2.1. Patients and controls
This study was approved by the Institutional Review Board of Taipei
Veterans General Hospital, Taipei, Taiwan and carried out in accordance
with The Code of Ethics of the World Medical Association (Declaration
of Helsinki). Informed consent was obtained from each participant be-
fore commencement of this study. Forty SCA3 patients were recruitedfor this study. Another 80 age- and sex-matched healthy subjects (40
for the MRS study and 40 for the MRI study) were recruited as the con-
trol groups. All SCA3 patients were evaluated by SARA. SARA score
(Schmitz-Hübsch et al., 2006), which was a rating of the severity of
ataxia symptoms ranging from 0 to 40, was used as a reference to indi-
cate the progression of clinical severity in comparison with the cerebel-
lar degeneration. A self-reported AO was acquired from each patient.
The AO was deﬁned as the age at which the patients showed the ﬁrst
sign of any ataxic symptom (Jardim et al., 2001). Disease duration was
calculated accordingly. Hereafter, capitalised Age and Duration repre-
sent the participants' age at the date of examination and the corre-
sponding disease duration (Duration is only available for the SCA3
patients), respectively. The CAG repeat length of each SCA3 patient
was determined by polymerase chain reaction, as described previously
(Soong et al., 2001). Disease duration-adjusted SARA scores (SARA/Du-
ration) of the SCA3 patients were computed. To explore the possible
nonlinear nature of the disease progression pattern of SCA3, we divided
the SCA3 patients into two subgroups according to a CAG repeat length
threshold of 74 (≥74 and b74). This criterion is based on themean CAG
repeat length (73.2 ± 4.0) of the SCA3 patients, and it can generate
more balanced sample sizes (22 vs 18) for the two subgroups. We con-
ﬁrmed that the control groups did not exhibit any central nervous dis-
ease or neurological abnormalities before or during the study period.
In addition, the T1- and T2-weighted images of the control groups
were examined to ensure the absence of latent neurological diseases
or unexpected abnormalities.
2.2. Image acquisition
Brain MRI and MRS images were obtained using a 1.5-T system
(Signa EXCITE, GEMedical Systems, Milwaukee,WI, USA). TheMRI pro-
tocol involved an axial, T1-weighted, 3-dimensional, fast-spoiled, gradi-
ent-recalled acquisition of steady state images (TR [repetition time] =
8.58 ms, TE [echo time] = 3.62 ms, inversion time [TI] = 400 ms, slice
thickness = 1.5 mm) and an axial, T2-weighted, fast spin-echo se-
quence (TR = 4000 ms, TE = 256.5 ms, slice thickness = 5 mm).
AfterMRI imageswere acquired, protonMRSwas performedwith a sin-
gle-voxel, stimulated echo-acquisition mode sequence (TR/TE/mixing
time/excitations = 3000/15/13.7/96, spectral width = 2500 Hz, num-
ber of points = 2048, voxel size = 2 cm × 2 cm × 2 cm) in the regions
of the bilateral cerebellar hemispheres and the cerebellar vermis of sub-
jects. For each subject, the selection of the voxel of interest (VOI) was
performed by the same investigator to ensure consistent placement.
The locations of these VOIswere conﬁrmed to be accurate by 2 other in-
vestigators by overlaying the 3-dimensionalmaps on the corresponding
T2-weighted images. The precise locations of VOIs were described in
our previous study (Wang et al., 2012). The NAA and Cr measurements
were derived by software implemented in MRI equipment. Care was
taken to avoid the inclusion of cerebrospinal ﬂuid-ﬁlled spaces within
the VOIs. Peak areas for NAA at 2.02 parts per million (ppm) and crea-
tine (Cr) at 3.03 ppm were calculated using FuncTool software (GE
Healthcare, Milwaukee, WI, USA). Peak integral values were expressed
relative to the Cr peak. Three NAA/Cr ratios, namely Rt-Cb-NAA, Lt-Cb-
NAA, and V-NAA, were calculated. To ensure high-quality images, MRS
results with a full width at half maxima N6 Hz were disqualiﬁed from
the MRS analysis. According to this criterion, the value of Rt-Cb-NAA
in one subject, those of Lt-Cb-NAA in 2 subjects, and those of V-NAA
in 3 subjects were removed. Two values of V-NAA in the controls were
also unavailable.
2.3. 3D-FD value computation
FD analysis was originally proposed to quantify the shape complex-
ity of objects into a simple numerical value. Preprocessing was per-
formed before the computation of 3D-FD values according to T1-
weighted MRI results. The preprocessing procedures are illustrated in
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resampled to 1 × 1 × 1 mm by using ImageJ (Rasband WS, ImageJ, U.
S. National Institutes of Health, Bethesda, Maryland, USA, http://
imagej.nih.gov/ij/, 1997–2016) (Fig. 1(a)). Before the segmentation of
brain tissue, an automated skull-stripping function was applied to the
image volumes by using the brain extraction tool in MRIcro software
(Rorden C, University of Nottingham, UK; www.sph.sc.edu/comd/
rorden/mricro.html) (Fig. 1(b)). The skull-stripped images were then
normalised to the JHU_MNI_SS_T_ss T1 template by a 12-parameter
afﬁne transformation in the DiffeoMap toolbox (Li X, Jiang H, and Mori
S, Johns Hopkins University, www.MriStudio.org) (Fig. 1(c)). Brain seg-
mentation was performed using the SPM8 toolbox (Welcome Depart-
ment of Cognitive Neurology, Institute of Neurology, University
College London, London, UK, http://www.ﬁl.ion.ucl.ac.uk/spm/)
(Fig. 1(d)). Brain region labellingwas performed according to Individual
Brain Atlases using Statistical Parametric Mapping (IBASPM) (http://
www.thomaskoenig.ch/Lester/ibaspm.htm) toolbox in MATLAB
R2013b software (Mathworks, Natick, MA, USA). The brain cortex was
subsequently parcellated into 116 separate regions by using the Auto-
mated Anatomical Labelling (AAL) atlas based on IBASPM (Fig. 1(e)).
The 26 regions of the cerebellum were then merged into 7 regions,
namely the left anterior lobe, right anterior lobe, left posterior upper
lobe, right posterior upper lobe, left posterior lower lobe, right posterior
lower lobe, and vermis, according to their anatomical structures. Hence,
97 labelled brain regions were obtained for each subject (Fig. 1(f)).
In this study, we adopted the 3D box-counting method to calculate
the 3D-FD values of the 97 labelled brain regions for each subject. The
box-counting algorithm has been explained in our previous study
(Wu et al., 2010).2.4. Brain network analysis
To investigate whether different CAG repeat lengths cause a differ-
ence in the brain network of SCA3 patients, the patients whose disease
duration is not ≤5 years were excluded in each SCA3 subgroup for the
following brain network analysis. This criterion of disease duration
≤5 years was selected to minimise the effect of disease duration, to en-
sure that the data were representative of the network status close to the
AO. Moreover, the criterion ensured an adequate number of subjects in
each SCA3 subgroup as required for the brain network analysis. AfterFig. 1. Flowchart of image preprocessing. Each voxel of grey matter in the T1-weighted image w
regions weremerged into 7 cerebellar regions based on anatomical position, resulting in the ﬁn
interpretation of the references to colour in this ﬁgure legend, the reader is referred to the wethe exclusion of SCA3 patients who did not meet the criterion, 8 and 7
subjects were included in the subgroups with CAG b 74 and CAG ≥ 74,
respectively. Accordingly, 2 new control groups age- and sex-matched
to their corresponding SCA3 counterparts were formed, and they were
denoted by Control I and Control II. No healthy subject was repeatedly
selected into the 2 control groups.
After obtaining the 3D-FD values of 97 brain regions, we computed
the region-to-region correlations based on the derived 3D-FD values
and formed a 97 × 97 correlation matrix for each group. Subsequently,
the values in the correlation matrix with a p-value of b0.05 were set
to 1, and the remaining values in other entries were set to 0. This
binarised correlation matrix is called an adjacency matrix in graph the-
ory, in which 1 implies the presence of a link between 2 corresponding
brain regions (nodes) and 0 implies the absence of a link. Subsequently,
diagrams were created to illustrate the architecture of the cerebellar
networks on a glass brain template.2.5. Statistical analyses
All data are expressed asmean± standard deviation (x s). Outliers
of NAA/Cr ratios and 3D-FD values outside the range of mean ± 2 ×
standard deviation were removed in the subsequent analysis. Parame-
ters between the patients and controls, between the two patients
subgroups, and between the patients subgroups and controls were all
compared using the 2-sample t-test. The sex ratios were compared
using the Pearson chi-squared test. The Pearson correlation and a scatter
plot (Fig. 2) were used to display the relation between the CAG repeat
length and AO. The Pearson correlation between CAG repeat length
and SARA score/Duration was computed. A multivariate linear regres-
sion analysis was used to investigate how independent variables
(predictors), namely the AO, Duration, CAG repeat length, and the inter-
action term (AO:CAG), accounted for the variance of dependent
variables, namely SARA score, NAA/Cr ratios and 3D-FD values. A false
discovery rate (FDR) controlling procedure (Benjamini and Hochberg,
1995) was applied to reduce type I error caused by multiple compari-
sons in the regression model.
Scatter plots of the SARA score versus Duration (Fig. 3), NAA/Cr
ratios versus Duration (Fig. 4), and 3D-FD values versus Duration
(Fig. 5) were constructed to illustrate the degeneration patterns of the
SARA score, NAA/Cr ratios, and 3D-FD values, respectively, in the SCA3as labelled according to the 116 regions of the AAL atlas. Subsequently, the 26 cerebellar
al 97 labelled brain regions, which are displayed in different colours in the right panel. (For
b version of this article.)
Fig. 2. Graph of CAG repeat length versus onset age (AO).
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Duration, NAA/Cr ratios versus Duration, and 3D-FD values versus Dura-
tion between the SCA3 subgroups were tested using a linear regression
model.
3. Results
3.1. Cerebellar NAA/Cr ratios and 3D-FD values were lower in the SCA3
patients
The detailed demographic data, clinical data, NAA values, and 3D-FD
values of the participants are summarised in Table 1. The results of neu-
rological examination for extracerebellar symptoms were added into
the Appendix A. Supplementary data. No difference in agewas observed
between the SCA3 patients and the MRS control group (45.9 ± 11.9 vs
51.20 ± 17.58, p = 0.114) or the MRI control group (45.9 ± 11.9 vs
43.5 ± 11.2, p= 0.377). The SCA3 patients showed signiﬁcantly lower
NAA/Cr ratios than did the controls (all p b 0.001) in the right cerebel-
lum, left cerebellum, and vermis, and these ratios are respectively
outlined as follows: Rt-Cb-NAA, 0.82 ± 0.15 versus 1.00 ± 0.11; Lt-
Cb-NAA, 0.85±0.15 versus 1.00±0.13; and V-NAA, 0.78±0.10 versus
0.90±0.11. Similarly, the SCA3patients showed signiﬁcantly lower 3D-
FD values than did the controls in the right anterior lobe (2.02± 0.08 vs
2.10 ± 0.04, p b 0.001), left anterior lobe (2.08 ± 0.08 vs 2.12 ± 0.04,
p b 0.01), right posterior upper lobe (2.41 ± 0.04 vs 2.43 ± 0.02,Fig. 3. Graph of SARA score versus Duration. Stars represent the subgroup with CAG b 74,
and circles represent the subgroup with CAG ≥ 74. The dash line represents the common
slope of the SCA3 subgroups.p b 0.05), left posterior lower lobe (2.32 ± 0.06 vs 2.34 ± 0.04,
p b 0.05), and whole cerebellum (2.48 ± 0.04 vs 2.51 ± 0.02, p b 0.001).
3.2. SCA3 patients with a longer CAG repeat length demonstrated earlier
disease onset
Overall, the data of the recruited SCA3 patients revealed a negative
correlation between the CAG repeat length and AO (ρ = −0.709,
p b 0.001). The scatter plot of CAG repeat length versus AO was
displayed in Fig. 2.
3.3. CAG repeat length was not correlated with SARA score/Duration
The result showed that the CAG repeat length was not correlated
with SARA score/Duration (ρ = −0.059, p = 0.720). No difference
was observed in SARA score/Duration between the SCA3 subgroup
with CAG b 74 and the subgroup with CAG ≥ 74 (2.3 ± 1.4 vs 2.1 ±
1.3, p= 0.634) (Table 1).
3.4. CAG repeat length was not a signiﬁcant determinant of SARA score,
NAA/Cr ratios, and 3D-FD values
The results ofmultivariate linear regression are summarised in Table
2. The values in Table 2 represent the estimated coefﬁcient of thepredic-
tors. The results showed that Duration was signiﬁcantly correlatedwith
SARA score and all 3 cerebellar NAA/Cr ratios. However, Duration was
not correlated with any 3D-FD value. Besides, AO and the CAG repeat
length were not correlated with SARA score, NAA/Cr ratios and 3D-FD
values.
Similarly, analysing the SCA3 subgroups separately revealed that the
CAG repeat length was not a signiﬁcant determinant of SARA score, any
NAA/Cr ratio or 3D-FD value. The regression results for the two SCA3
subgroups are presented in the Appendix A. Supplementary data.
3.5. No difference in slopes of SARA score, NAA/Cr ratios, and 3D-FD values
versus Duration between the two SCA3 subgroups
Scatter plots of the SARA score, NAA/Cr ratios, and 3D-FD values ver-
susDuration are displayed in Figs. 3, 4, and 5, respectively. In these plots,
stars represent the SCA3 patients with CAG b 74 and circles represent
the SCA3 patients with CAG ≥ 74. Instead of drawing individual slopes
for each SCA3 subgroup, we drew only the common slope of the 2 sub-
groups to accentuate the fact that no signiﬁcant differencewas observed
in the degeneration rate of these parameters versus Duration.
The scatter plot of the SARA score versus Duration is shown in Fig. 3.
No signiﬁcant difference was observed in the slopes of SARA scores ver-
sus Duration between the two SCA3 subgroups (F = 0.37, p= 0.549).
The scatter plots of Rt-Cb-NAA, Lt-Cb-NAA, and V-NAA versus Duration
are displayed in Fig. 4(a), (b), and (c), respectively. The tests of slope
parallelism revealed no difference in Rt-Cb-NAA versus Duration (F =
1.15, p = 0.291), Lt-Cb-NAA versus Duration (F = 0.04, p = 0.847),
and V-NAA versus Duration (F = 0.67, p = 0.419) between the SCA3
subgroups. The scatter plots of FD values in the left anterior lobe (Lt-
A-FD), right anterior lobe (Rt-A-FD), left posterior upper lobe (Lt-PU-
FD), right posterior upper lobe (Rt-PU-FD), left posterior lower lobe
(Lt-PL-FD), right posterior lower lobe (Rt-PL-FD), and whole volume
(Cb-FD) of the cerebellum versus Duration are displayed in Fig. 5(a),
(b), (c), (d), (e), (g), and (h), respectively. No signiﬁcant difference
was observed in the slopes of Lt-A-FD versus Duration (F = 1.19, p =
0.283), Rt-A-FD versus Duration (F= 0.34, p=0.564), Lt-PU-FD versus
Duration (F = 0, p= 0.987), Rt-PU-FD versus Duration (F = 0.32, p=
0.577), Lt-PL-FD versus Duration (F=0.14, p=0.707), Rt-PL-FD versus
Duration (F = 1.26, p = 0.269), V-FD versus Duration (F = 0.18, p =
0.678), and Cb-FD versus Duration (F = 0.63, p= 0.434) between the
SCA3 subgroups.
Fig. 4. Graphs of NAA/Cr ratios versus Duration. (a) Rt-Cb-NAA versus Duration, (b) Lt-Cb-NAA versus Duration, and (c) V-NAA versus Duration. Stars represent the subgroup with
CAG b 74, and circles represent the subgroup with CAG ≥ 74. The dash lines represent the common slopes of the SCA3 subgroups.
101S.-R. Huang et al. / NeuroImage: Clinical 13 (2017) 97–1053.6. Network dissociation was found in the SCA3 subgroup with CAG ≥ 74
The demographic and clinical data used in the network analysis are
presented in Table 3. The SCA3 subgroups with CAG b 74 and
CAG ≥ 74 comprised 8 subjects (M/F = 5/3) and 7 subjects (M/F =
6/1), respectively. A signiﬁcant difference was observed in Age
(50.5 ± 10.6 vs 32.4 ± 5.9, p b 0.001), the AO (48.1 ± 11.2 vs 28.7 ±
5.9, p b 0.01), and the CAG repeat length (69.0 ± 3.0 vs 76.0 ± 2.4,
p b 0.001) between the SCA3 subgroups. By contrast, no signiﬁcant
difference was observed in Duration (2.4 ± 1.2 vs 3.7 ± 1.3, p =
0.051), SARA score (6.9 ± 3.8 vs 9.6 ± 7.8, p = 0.396), and SARA
score/Duration (3.2 ± 1.7 vs 2.6 ± 1.8, p = 0.533) between the two
SCA3 subgroups.
The numbers of total links in the structural covariance networks
were 444 in Control I, 385 in Control II, 355 in the SCA3 subgroup
with CAG b 74, and 259 in the SCA3 subgroup with CAG ≥ 74. The
brain networks of the controls and SCA3 patients are illustrated in
Fig. 6(a)–(d), in which only cerebellum-associated links and nodes are
plotted. The nodes in the samebrain region are coded in the same colour
(refer to the ﬁgure caption for details). The links are colour coded de-
pending on which corresponding nodes (frontal, parietal, temporal,
etc.) are connected to the cerebellar nodes (refer to the ﬁgure caption
for details).Fig. 5. Graphs of 3D-FD values versus Duration. (a) Lt-A-FD versus Duration, (b) Rt-A-FD versus
Duration, (f) Rt-PL-FD versus Duration, (g) V-FD versus Duration, and (h) Cb-FD versus Durati
CAG ≥ 74. The dash lines represent the common slopes of the SCA3 subgroups. Lt-A-FD: left an
PU-FD: right posterior upper lobe FD, Lt-PL-FD: left posterior lobe FD, Rt-PL-FD: right posteriorThe cerebellar networks in Controls I and II displayed many links
between the cerebellar nodes and the nodes in the frontal (red), parietal
(green), temporal (yellow), occipital (blue), and other regions (Fig. 6(a)
and (b)). Speciﬁcally considering the parietal-occipital lobes (green-
blue) revealed that of the 28 parietal-occipital regions in 116 regions
of the AAL atlas, 11 regions (approximately 39.3%) in Control I and 14
regions (approximately 50.0%) in Control II were connected to the
cerebellar regions (Fig. 6(a) and (b)). A similar connection pattern
was observed in the SCA3 subgroupwith CAG b 74, inwhich 6 (6/28, ap-
proximately 21.4%) parietal-occipital regions were connected to the
cerebellar regions (Fig. 6(c)). However, a marked dissociation of the
brain network between the parietal-occipital regions and cerebellar re-
gions was found for the subgroup with CAG ≥ 74, in which only 2 (2/28,
approximately 7.1%) parietal-occipital regions were connected to the
cerebellar regions (Fig. 6(d)).
4. Discussion
4.1. NAA/Cr ratios and 3D-FD values can indicate cerebellar degeneration in
SCA3
According to Table 1, Rt-Cb-NAA, Lt-Cb-NAA, V-NAA, Lt-A-FD, Rt-A-
FD, Rt-PU-FD, Lt-PL-FD, and Cb-FD were signiﬁcantly lower in the SCA3Duration, (c) Lt-PU-FD versus Duration, (d) Rt-PU-FD versus Duration, (e) Lt-PL-FD versus
on. Stars represent the subgroup with CAG b 74, and circles represent the subgroup with
terior lobe FD, Rt-A-FD: right anterior lobe FD, Lt-PU-FD: left posterior upper lobe FD, Rt-
lobe FD, V-FD: vermis FD, Cb-FD: FD of the whole cerebellum.
Table 1
Demographic data, clinical data, MRS NAA measurements, and MRI 3D-FD measurements derived from controls and SCA3 patients.
Variables Control (n = 40) SCA3 (n = 40) SCA3 SCA3 p-Value
CAG b 74 (n= 22) CAG ≥ 74 (n= 18)
Age of onset (AO) (year) ND 38.1 ± 10.9 44.9 ± 9.5 29.9 ± 5.6 b0.001⁎⁎⁎
Duration (year) ND 7.7 ± 5.0 7.8 ± 5.6 7.7 ± 4.4 0.962
SARA ND 14.2 ± 8.6 13.8 ± 8.2 14.8 ± 9.3 0.725
CAG repeat length ND 73.2 ± 4.0 70.3 ± 2.4 76.7 ± 2.4 b0.001⁎⁎⁎
SARA/Duration (year) ND 2.2 ± 1.3 2.3 ± 1.4 2.1 ± 1.3 0.634
MRS study:
Age (year) 51.20 ± 17.58 45.9 ± 11.9 52.7 ± 10.8 37.6 ± 6.9†† b0.001⁎⁎⁎
M/F 20/20 20/20 10/12 10/8 0.526a
Rt-Cb-NAA 1.00 ± 0.11 0.82 ± 0.15††† 0.79 ± 0.17††† 0.85 ± 0.12††† 0.172
Lt-Cb-NAA 1.00 ± 0.13 0.85 ± 0.15††† 0.81 ± 0.13††† 0.91 ± 0.16† 0.043⁎
V-NAA 0.90 ± 0.11 0.78 ± 0.10††† 0.76 ± 0.08††† 0.81 ± 0.12†† 0.196
MRI study:
Age (year) 43.5 ± 11.2 45.9 ± 11.9 52.7 ± 10.8†† 37.6 ± 6.9† b0.001⁎⁎⁎
M/F 20/20 20/20 10/12 10/8 0.526a
Lt-A-FD 2.12 ± 0.04 2.08 ± 0.08†† 2.07 ± 0.07††† 2.10 ± 0.08 0.168
Rt-A-FD 2.10 ± 0.04 2.02 ± 0.08††† 1.99 ± 0.08††† 2.05 ± 0.07†† 0.007⁎⁎
Lt-PU-FD 2.43 ± 0.02 2.42 ± 0.04 2.43 ± 0.03 2.41 ± 0.05 0.319
Rt-PU-FD 2.43 ± 0.02 2.41 ± 0.04† 2.40 ± 0.04†† 2.41 ± 0.05 0.565
Lt-PL-FD 2.34 ± 0.04 2.32 ± 0.06† 2.33 ± 0.04 2.31 ± 0.08† 0.307
Rt-PL-FD 2.36 ± 0.03 2.36 ± 0.06 2.37 ± 0.04 2.34 ± 0.08 0.307
V-FD 2.16 ± 0.05 2.14 ± 0.05 2.14 ± 0.05 2.14 ± 0.06 0.997
Cb-FD 2.51 ± 0.02 2.48 ± 0.04††† 2.48 ± 0.03††† 2.47 ± 0.05†† 0.949
SARA: SARA score, Rt: right, Lt: left, Cb: cerebellar, V: vermis, NAA: NAA/Cr ratio, Lt-A-FD: left anterior lobe FD, Rt-A-FD: right anterior lobe FD, Lt-PU-FD: left posterior upper lobe FD, Rt-
PU-FD: right posterior upper lobe FD, Lt-PL-FD: left posterior lobe FD, Rt-PL-FD: right posterior lobe FD, V-FD: vermis FD, Cb-FD: FD of the whole cerebellum.
† p b 0.05 represents signiﬁcant difference compared with controls.
†† p b 0.01 represents signiﬁcant difference compared with controls.
††† p b 0.001 represents signiﬁcant difference compared with controls.
⁎ p b 0.05 represents signiﬁcant difference between the two SCA3 subgroups.
⁎⁎ p b 0.01 represents signiﬁcant difference between the two SCA3 subgroups.
⁎⁎⁎ p b 0.001 represents signiﬁcant difference between the two SCA3 subgroups.
a Chi-squared test.
102 S.-R. Huang et al. / NeuroImage: Clinical 13 (2017) 97–105patients than in the controls. These results indicate that SCA3 affects not
only the patients' cerebellar function but also the structure of the cere-
bellar cortex, and they are consistent with the ﬁndings in previous re-
ports based on cerebellar NAA measurements (Adanyeguh et al., 2015;
Wang et al., 2012), MRI volumetry (Stefanescu et al., 2015) and fMRI
(Stefanescu et al., 2015). Moreover, our study ﬁndings demonstrate
that NAA/Cr and 3D-FD measurements can successfully detect disease
involvement in the cerebellar regions.Table 2
Coefﬁcients of the AO, Duration, CAG repeat length, and AO:CAG in themultivariate linear
regression analysis.
Predictors (Xi) Intercept AO Duration CAG AO:CAG
Dependent variables (Y)
SARA score −74.222 1.947 1.322⁎⁎⁎ 1.079 −0.027
Rt-Cb-NAA 2.376 −0.028 −0.017⁎⁎ −0.016 ~0
Lt-Cb-NAA 1.733 0.001 −0.014⁎ −0.006 ~0
V-NAA 0.343 0.010 −0.011⁎⁎ 0.008 ~0
Lt-A-FD 1.507 0.026 ~0 0.010 ~0
Rt-A-FD 1.206 0.027 −0.002⁎⁎⁎ 0.013 ~0
Lt-PU-FD 1.973⁎⁎ 0.019 −0.001 0.007 ~0
Rt-PU-FD 2.035⁎⁎ 0.015 ~0 0.006 ~0
Lt-PL-FD 2.003 0.014 ~0 0.005 ~0
Rt-PL-FD 2.026⁎ 0.012 ~0 0.005 ~0
V-FD 1.886⁎ 0.015 −0.003 0.005 ~0
Cb-FD 2.079⁎⁎ 0.013 ~0 0.006 ~0
Rt: right, Lt: left, Cb: cerebellar, NAA: NAA/Cr ratio, V: vermis, Lt-A-FD: left anterior lobe
FD, Rt-A-FD: right anterior lobe FD, Lt-PU-FD: left posterior upper lobe FD, Rt-PU-FD:
right posterior upper lobe FD, Lt-PL-FD: left posterior lobe FD, Rt-PL-FD: right posterior
lobe FD, V-FD: vermis FD, Cb-FD: FD of the whole cerebellum. CAG: CAG repeat length.
AO: age of disease onset. AO:CAG: interaction term of AO and CAG.
⁎ p b 0.05 represents signiﬁcance (FDR corrected).
⁎⁎ p b 0.01 represents signiﬁcance (FDR corrected).
⁎⁎⁎ p b 0.001 represents signiﬁcance (FDR corrected).4.2. CAG repeat length is not correlated with SARA score and SARA score/
Duration
SARA score was found to be insigniﬁcantly correlated with the CAG
repeat length of SCA3 patients in this study. A similar result is reported
in longitudinal cohort studies (Jacobi et al., 2011; Jacobi et al., 2015). Ad-
ditionally, SARA score/Duration represents the progression rate of the
severity of clinical symptoms. In this study, SARA score/Duration was
not correlated with the CAG repeat length of SCA3 patients. Moreover,
the average SARA score/Duration values were not different between
the SCA3 subgroup with CAG b 74 and that with CAG ≥ 74. This ﬁnding
is consistent with those in previous reports that have shown that the
duration-adjusted International Cooperative Ataxia Rating Scale
(ICARS) score (França et al., 2009) and duration-adjusted SARA score
(Zhou et al., 2011) were not correlated with the CAG repeat length in
SCA3 patients.
These results seem contradictory to those of Klockgether et al., who
suggested that a longer CAG repeat length could result in more rapid
disease progression in SCA3 patients (Klockgether et al., 1998a).
Klockgether et al., classiﬁed disease progression into 4 stages depending
on the difﬁculties faced by patients: stage 1, gait difﬁculties; stage 2, de-
pendence on walking aids; stage 3, wheelchair-bound stage; and stage
4, death. The negative results can be explained by the reason that the
progression of the clinical ratings, ICARS and SARA, do not equate to
the progression of disease stages.4.3. CAG repeat length does not signiﬁcantly affect cerebellar degeneration
rate
In this study,we hypothesised that the CAG repeat lengthmay accel-
erate damage to the cerebellar regions of SCA3 patients. However, our
results do not support this hypothesis.
Table 3
Demographic and clinical information of the subjects used in the brain network analysis.
Variables Control I (n = 8) Control II (n = 7) SCA3 SCA3 p-Value
CAG b 74 (n= 8) CAG ≥ 74 (n= 7)
Age (year) 50.3 ± 7.9 32.7 ± 7.6††† 50.5 ± 10.6 32.4 ± 5.9 b0.001⁎⁎⁎
M/F 5/3 6/1 5/3 6/1 0.310a
Age of onset (AO) (year) ND ND 48.1 ± 11.2 28.7 ± 5.9 0.001⁎⁎
Duration (year) ND ND 2.4 ± 1.2 3.7 ± 1.3 0.051
SARA ND ND 6.9 ± 3.8 9.6 ± 7.8 0.396
CAG repeat length ND ND 69.0 ± 3.0 76.0 ± 2.4 b0.001⁎⁎⁎
SARA/Duration (year) ND ND 3.2 ± 1.7 2.6 ± 1.8 0.533
No signiﬁcant difference was observed between the SCA3 subgroups and their corresponding control groups.
⁎⁎ p b 0.01 represents the signiﬁcant difference between the two SCA3 subgroups.
⁎⁎⁎ p b 0.001 represents the signiﬁcant difference between the two SCA3 subgroups.
††† p b 0.001 represents the signiﬁcant difference between the two control groups.
a Chi-squared test.
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peat length was not a signiﬁcant determinant of cerebellar NAA/Cr
ratios and 3D-FD values. This ﬁnding implies that these cerebellar
NAA/Cr ratios and 3D-FD values show a similar decline rate in
SCA3 patients after the onset of symptoms, regardless of their
CAG repeat lengths. Moreover, a nonlinear decline rate of the cere-
bellar NAA/Cr ratios and 3D-FD values was not observed between
the SCA3 subgroup with CAG b 74 and that with CAG ≥ 74. In sum-
mary, the CAG repeat length does not exert a signiﬁcant inﬂuence
on the degeneration rate of cerebellar function and cerebellar
structure.Fig. 6. Cerebellar networks of SCA3 patients and controls. (a) Control I (control group for CAG b
SCA3 subgroup with CAG ≥ 74. In the diagrams, the nodes in the same brain region are coded
temporal lobes, purple: limbic system, cyan: subcortical region, and pink: cerebellum). The lin
parietal lobes, blue: occipital lobes, yellow: temporal lobes, purple: limbic system, cyan: subco
ﬁgure legend, the reader is referred to the web version of this article.)Similar ﬁndings are adequately reported in the literature.
Adanyeguh et al. reported that the CAG repeat lengthwas not correlated
with the sum ofN-acetylaspartate andN-acetylaspartylglutamate in the
cerebellar vermis based on a MRS study (Adanyeguh et al., 2015). In
regard to the MRI studies, by using the measure of normalised volume,
Klockgether et al. ﬁrst reported no correlation between the CAG repeat
length and the atrophy of cerebellar regions in 11 SCA3 patients
(Klockgether et al., 1998b). Subsequently, the same results were found
for a higher number of recruited patients (Eichler et al., 2011; Schulz
et al., 2010) and in a longitudinal study (Reetz et al., 2013). Recently, a
study based on a 7-T MRI modality demonstrated that the CAG repeat74), (b) Control II (control group for CAG ≥ 74), (c) SCA3 subgroupwith CAG b 74, and (d)
in the same colour (red: frontal lobes, green: parietal lobes, blue: occipital lobes, yellow:
ks connecting the lobes with the cerebellum are colour coded (red: frontal lobes, green:
rtical region, and pink: cerebellum). (For interpretation of the references to colour in this
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dentate nuclei (Stefanescu et al., 2015). In addition to those neuroimag-
ing reports, a pathoanatomy study also demonstrated that the CAG re-
peat length was not correlated with the atrophy of the four deep
cerebellar nuclei (fastigial nucleus, globose nucleus, emboliform nucle-
us and dentate nucleus) (Scherzed et al., 2012).
The lack of correlative relationship between the CAG repeat length
and the cerebellar degeneration rate is unexpected. So far, the underly-
ing mechanism about how CAG repeat length and other factors control
neurodegeneration in SCA3 is unclear. Some studies reported that SCA3
patients could have extracerebellar involvements (Rüb et al., 2008;
Rezende et al., 2015; Yamada et al., 2004). Other studies found the de-
generation of cerebral regions, basal ganglia, brain stem, spinal cord
and white matter in SCA3 is also correlated with SARA score or ICARS
score (D'Abreu et al., 2012; Fahl et al., 2015; Kang et al., 2014;
Rezende et al., 2015; Schulz et al., 2010). These results indicate that
not only the atrophy of cerebellum but also the degeneration of any
brain region in the central nervous loop that modulates motor function
may arise in ataxia symptoms (Rüb et al., 2008; Schmahmann and
Pandya, 2008). Taken together, it is inferred that the earlier onset of
ataxia symptoms in the SCA3 patients with a longer CAG repeat length
may not be attributed to the more rapid cerebellar degeneration
alone. It motivated us to explore whether the SCA3 patients with a lon-
ger CAG repeat length may have a different structural covariance net-
work in comparison with those with a shorter CAG repeat length.
4.4. SCA3 patients with longer CAG repeat lengths display dissociation of
structural covariance networks between the parietal-occipital lobes and
the cerebellum
Our results show that the number of total links in the network and
the number of links between the parietal-occipital nodes and the cere-
bellum were slightly different between Control I and Control II, even
though the average age of Control I (50.3± 7.9 years) wasmuch higher
than that of Control II (32.7 ± 7.6 years). This ﬁnding suggests that age
does not cause amajor difference in the representation of the structural
covariance network. However, among the 4 groups, the SCA3 subgroup
with CAG ≥ 74 exhibited the fewest total links in the network and the
fewest links with the cerebellar regions. Moreover, a disconnection of
networks between the parietal-occipital and the cerebellar regions
was observed in the SCA3 subgroup with CAG ≥ 74 (mean age =
32.4 ± 5.9 years); by contrast, the disconnection was only mild in the
subgroup with CAG b 74 (mean age = 50.5 ± 10.6 years), even though
these groups did not exhibit differences in Duration, SARA score, and
SARA score/Duration. This result indicates that the SCA3 subgroup
with CAG ≥ 74 exhibited dissociated structural covariance networks.
Caution should be exercised when interpreting the results of struc-
tural networks constructed according to morphological covariance
(e.g., tissue volume, cortical thickness, surface area, concentration, and
3D-FD). The structural covariancemay arise fromgenetic inﬂuence, nor-
mal development, ageing, mutual trophic inﬂuences, or experience-re-
lated plasticity (Alexander-Bloch et al., 2013; Evans, 2013). In this
study, we did not regress out the effect of age, because of the small sam-
ple sizes; the removal of the age effect would result in the disqualiﬁca-
tion of most links after the thresholding of their p-values. Ageing
provides a crucial basis of the covariance of 3D-FD values across a
group of subjects to preserve an appropriate number of links in the net-
work analysis. Hence, we may assume that the links of the network in
Control I and Control II result from morphological changes induced
mainly by ageing. Therefore, the decoupling of links in the SCA3 sub-
groups only reveals that the disease disrupts the structural covariance
between paired brain regions through ageing. The cause of the network
dissociation between the parietal-occipital regions and the cerebellar
regions in the SCA3 patients with CAG ≥ 74 is not yet clearly known.
However, SCA3 patients are reported to exhibit widespread disease in-
volvement throughout the brain including parietal-occipital regions(D'Abreu et al., 2012; Rezende et al., 2015; Wang et al., 2015; Yamada
et al., 2004). A longer CAG repeat length may result in unbalanced atro-
phy on the cortex of the parietal-occipital and cerebellar lobes across
SCA3 patients, causing the disruption of the structural covariance be-
tween parietal-occipital lobes and the cerebellum.
Previous studies have identiﬁed changes in the brain network in
other genotypes of SCAs caused by mutated CAG expansion. The alter-
ation of the brain network is found to be associated with disease sever-
ity and disease duration in SCA1 (Solodkin et al., 2011), cognitive and
motor performance (Hernandez-Castillo et al., 2015) and onset of
parkinsonism in SCA2 (Wu et al., 2013), visual task performance
in SCA6 (Falcon et al., 2015) and CAG repeat length in SCA7
(Hernandez-Castillo et al., 2013). These studies, although mostly
based on fMRI, suggest that brain network alteration is associated
with clinical variables such as the CAG repeat length, disease severity,
disease duration, and task performance in SCAs. The current study is
theﬁrst to adopt the concept of structural covariance networks to inves-
tigate SCAs, and the results demonstrate that the CAG repeat lengthmay
affect the cerebellar structural network architecture of SCA3 patients.
Taken together, these results demonstrate that these SCAsmay be relat-
ed to ‘disconnection syndrome’ (Schmahmann and Pandya, 2008).
4.5. Study limitations
This study has several limitations. First, only the cortical atrophy of
grey matter wasmeasured by the 3D-FDmethod in this study. Cerebel-
lar white matter, cerebellar peduncles, and cerebellar deep nuclei, such
as dentate nucleus, are notwithin the scope of this study. This is because
thehardware limitation of the imagingmodality and thepulse sequence
limit the ability to clearly delineate the contours of deep nuclei. More-
over, an automated method to segment these structures is lacking. Sec-
ond, the sample sizes of the groups included in the brain network
analysis might not be sufﬁcient. Third, cross-sectional data of the SCA3
patients were used in this study, and the data were collected after AO,
with varied disease duration. Hence, a longitudinal study involving the
collection of data before, after, and at the disease onset should be con-
ducted. Lastly, in this study, we divided the SCA3 patients into two sub-
groups according to a CAG repeat length threshold of 74 (≥74 and b74)
to generate two subgroupswith balanced sample sizes (22 vs 18). How-
ever, different threshold choice might lead to different ﬁndings.
5. Conclusions
This study demonstrates that the function and cortical structure of
the cerebellum of SCA3 patients are impaired by the disease, which
can be detected byMRSNAA/Cr andMRI 3D-FDmeasures. Nevertheless,
we could not ﬁnd any evidence to support that the CAG repeat length
exerts a signiﬁcant impact on the decline rate of cerebellar function
and the atrophy rate of the cerebellar cortex based on NAA/Cr ratios
and 3D-FD values. In addition, no correlation was found between the
CAG repeat length and SARA score, and between the CAG repeat length
and SARA score/Duration in this study. However, a dissociation of the
structural covariance network was noted in the SCA3 subgroup with a
CAG repeat length ≥ 74, but not in the subgroup with a CAG repeat
length b 74. These results suggest that a longer CAG repeat length is
not associated with more rapid degeneration of the SARA score or cere-
bellar function and structure. Nevertheless, a longer CAG repeat length
is associated with the disruption of the morphological covariance be-
tween paired brain regions. An expansive quantitative network analysis
is required to verify this ﬁnding in the future.
Acknowledgements
This work was supported by grants from Ministry of Science and
Technology (MOST 103-2221-E-010-003-MY3) and Taiwan National
Health Research Institutes (NHRI-EX105-10526EI).
105S.-R. Huang et al. / NeuroImage: Clinical 13 (2017) 97–105Appendix A. Supplementary data
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.nicl.2016.11.007.
References
Adanyeguh, I.M., Henry, P.G., Nguyen, T.M., Rinaldi, D., Jauffret, C., Valabregue, R., Emir,
U.E., Deelchand, D.K., Brice, A., Eberly, L.E., 2015. In vivo neurometabolic proﬁling in
patients with spinocerebellar ataxia types 1, 2, 3, and 7. Mov. Disord. 30, 662–670.
Alexander-Bloch, A., Giedd, J.N., Bullmore, E., 2013. Imaging structural co-variance be-
tween human brain regions. Nat. Rev. Neurosci. 14, 322–336.
Bachelard, H., Badar-Goffer, R., 1993. NMR spectroscopy in neurochemistry. J. Neurochem.
61, 412–419.
Benjamini, Y., Hochberg, Y., 1995. Controlling the false discovery rate: a practical and
powerful approach to multiple testing. J. R. Stat. Soc. Ser. B Methodol. 289–300.
Braun, U., Muldoon, S.F., Bassett, D.S., 2009. On human brain networks in health and dis-
ease. eLS.
D'Abreu, A., Franca Jr., M.C., Yasuda, C.L., Campos, B.A., Lopes-Cendes, I., Cendes, F., 2012.
Neocortical atrophy in Machado-Joseph disease: a longitudinal neuroimaging study.
J. Neuroimaging 22, 285–291.
do Carmo Costa, M., Paulson, H.L., 2012. Toward understanding Machado–Joseph disease.
Prog. Neurobiol. 97, 239–257.
Durr, A., Stevanin, G., Cancel, G., Duyckaerts, C., Abbas, N., Didierjean, O., Chneiweiss, H.,
Benomar, A., Lyon-Caen, O., Julien, J., 1996. Spinocerebellar ataxia 3 andMachado-Joseph
disease: clinical, molecular, and neuropathological features. Ann. Neurol. 39, 490–499.
Eichler, L., Bellenberg, B., Hahn, H., Köster, O., Schöls, L., Lukas, C., 2011. Quantitative as-
sessment of brain stem and cerebellar atrophy in spinocerebellar ataxia types 3 and
6: impact on clinical status. Am. J. Neuroradiol. 32, 890–897.
Evans, A.C., 2013. Networks of anatomical covariance. NeuroImage 80, 489–504.
Fahl, C.N., Branco, L.M.T., Bergo, F.P., D'Abreu, A., Lopes-Cendes, I., França Jr., M.C., 2015.
Spinal cord damage in Machado-Joseph disease. Cerebellum 14, 128–132.
Falcon, M., Gomez, C., Chen, E., Shereen, A., Solodkin, A., 2015. Early cerebellar network
shifting in spinocerebellar ataxia type 6. Cereb. Cortex, bhv154.
França, M.C., D'Abreu, A., Nucci, A., Cendes, F., Lopes-Cendes, I., 2009. Progression of ataxia
in patients with Machado-Joseph disease. Mov. Disord. 24, 1387–1390.
Friston, K.J., 1994. Functional and effective connectivity in neuroimaging: a synthesis.
Hum. Brain Mapp. 2, 56–78.
Gong, G., He, Y., Chen, Z.J., Evans, A.C., 2012. Convergence and divergence of thickness cor-
relations with diffusion connections across the human cerebral cortex. NeuroImage
59, 1239–1248.
Guimaraes, R.P., D'Abreu, A., Yasuda, C.L., França, M.C., Silva, B.H., Cappabianco, F.A., Bergo,
F.P., Lopes-Cendes, I.T., Cendes, F., 2013. A multimodal evaluation of microstructural
white matter damage in spinocerebellar ataxia type 3. Mov. Disord. 28, 1125–1132.
Ha, T.H., Yoon, U., Lee, K.J., Shin, Y.W., Lee, J.-M., Kim, I.Y., Ha, K.S., Kim, S.I., Kwon, J.S.,
2005. Fractal dimension of cerebral cortical surface in schizophrenia and obsessive–
compulsive disorder. Neurosci. Lett. 384, 172–176.
Hernandez-Castillo, C.R., Alcauter, S., Galvez, V., Barrios, F.A., Yescas, P., Ochoa, A., Garcia,
L., Diaz, R., Gao, W., Fernandez-Ruiz, J., 2013. Disruption of visual and motor connec-
tivity in spinocerebellar ataxia type 7. Mov. Disord. 28, 1708–1716.
Hernandez-Castillo, C.R., Galvez, V., Mercadillo, R.E., Díaz, R., Yescas, P., Martinez, L.,
Ochoa, A., Velazquez-Perez, L., Fernandez-Ruiz, J., 2015. Functional connectivity
changes related to cognitive and motor performance in spinocerebellar ataxia type
2. Mov. Disord. 30, 1391–1399.
Jacobi, H., Bauer, P., Giunti, P., Labrum, R., Sweeney, M., Charles, P., Dürr, A., Marelli, C.,
Globas, C., Linnemann, C., 2011. The natural history of spinocerebellar ataxia type 1,
2, 3, and 6: a 2-year follow-up study. Neurology 77, 1035–1041.
Jacobi, H., du Montcel, S.T., Bauer, P., Giunti, P., Cook, A., Labrum, R., Parkinson, M.H., Durr,
A., Brice, A., Charles, P., 2015. Long-term disease progression in spinocerebellar ataxia
types 1, 2, 3, and 6: a longitudinal cohort study. Lancet Neurol. 14, 1101–1108.
Jardim, L.B., Pereira, M.L., Silveira, I., Ferro, A., Sequeiros, J., Giugliani, R., 2001. Neurologic
ﬁndings in Machado-Joseph disease: relation with disease duration, subtypes, and
(CAG) n. Arch. Neurol. 58, 899–904.
Kang, J.-S., Klein, J., Baudrexel, S., Deichmann, R., Nolte, D., Hilker, R., 2014. White matter
damage is related to ataxia severity in SCA3. J. Neurol. 261, 291–299.
Kawaguchi, Y., Okamoto, T., Taniwakiz, M., Aizawa, M., 1994. CAG expansions in a novel
gene for Machado-Joseph disease at. Nat. Genet. 8, 221–228.
King, R.D., Brown, B., Hwang, M., Jeon, T., George, A.T., Initiative, A.S.D.N., 2010. Fractal di-
mension analysis of the cortical ribbon in mild Alzheimer's disease. NeuroImage 53,
471–479.
Klockgether, T., Lüdtke, R., Kramer, B., Abele, M., Bürk, K., Schöls, L., Riess, O., Laccone, F.,
Boesch, S., Lopes-Cendes, I., 1998a. The natural history of degenerative ataxia: a ret-
rospective study in 466 patients. Brain 121, 589–600.
Klockgether, T., Skalej, M., Wedekind, D., Luft, A., Welte, D., Schulz, J., Abele, M., Bürk, K.,
Laccone, F., Brice, A., 1998b. Autosomal dominant cerebellar ataxia type I. MRI-
based volumetry of posterior fossa structures and basal ganglia in spinocerebellar
ataxia types 1, 2 and 3. Brain 121, 1687–1693.
Koeppen, A.H., 2005. The pathogenesis of spinocerebellar ataxia. Cerebellum 4, 62–73.
Lerch, J.P., Worsley, K., Shaw, W.P., Greenstein, D.K., Lenroot, R.K., Giedd, J., Evans, A.C.,
2006. Mapping anatomical correlations across cerebral cortex (MACACC) using corti-
cal thickness from MRI. NeuroImage 31, 993–1003.Lirng, J.-F., Wang, P.-S., Chen, H.-C., Soong, B.-W., Guo, W.Y., Wu, H.-M., Chang, C.-Y., 2012.
Differences between spinocerebellar ataxias and multiple system atrophy-cerebellar
type on proton magnetic resonance spectroscopy. PLoS One 7, e47925.
Maciel, P., Gaspar, C., DeStefano, A.L., Silveira, I., Coutinho, P., Radvany, J., Dawson, D.M.,
Sudarsky, L., Guimarães, J., Loureiro, J.E., 1995. Correlation between CAG repeat length
and clinical features in Machado-Joseph disease. Am. J. Hum. Genet. 57, 54.
Onodera, O., Idezuka, J., Igarashi, S., Takiyama, Y., Endo, K., Takano, H., Oyake, M., Tanaka,
H., Inuzuka, T., Hayashi, T., 1998. Progressive atrophy of cerebellum and brainstem as
a function of age and the size of the expanded CAG repeats in the MJD1 gene in
Machado-Joseph disease. Ann. Neurol. 43, 288–296.
Pedroso, J.L., França, M.C., Braga-Neto, P., D'Abreu, A., Saraiva-Pereira, M.L., Saute, J.A.,
Teive, H.A., Caramelli, P., Jardim, L.B., Lopes-Cendes, I., 2013. Nonmotor and
extracerebellar features in Machado-Joseph disease: a review. Mov. Disord. 28,
1200–1208.
Reetz, K., Costa, A.S., Mirzazade, S., Lehmann, A., Juzek, A., Rakowicz, M., Boguslawska, R.,
Schöls, L., Linnemann, C., Mariotti, C., 2013. Genotype-speciﬁc patterns of atrophy
progression are more sensitive than clinical decline in SCA1, SCA3 and SCA6. Brain
136, 905–917.
Rezende, T., D'Abreu, A., Guimarães, R., Lopes, T., Lopes-Cendes, I., Cendes, F., Castellano,
G., França, M., 2015. Cerebral cortex involvement in Machado–Joseph disease. Eur.
J. Neurol. 22, 277-e224.
Rüb, U., Brunt, E.R., Deller, T., 2008. New insights into the pathoanatomy of
spinocerebellar ataxia type 3 (Machado–Joseph disease). Curr. Opin. Neurol. 21,
111–116.
Rubinov, M., Sporns, O., 2010. Complex networkmeasures of brain connectivity: uses and
interpretations. NeuroImage 52, 1059–1069.
Sandu, A.-L., Rasmussen, I.-A., Lundervold, A., Kreuder, F., Neckelmann, G., Hugdahl, K.,
Specht, K., 2008. Fractal dimension analysis of MR images reveals grey matter struc-
ture irregularities in schizophrenia. Comput. Med. Imaging Graph. 32, 150–158.
Scherzed, W., Brunt, E., Heinsen, H., de Vos, R., Seidel, K., Bürk, K., Schöls, L., Auburger, G.,
Del Turco, D., Deller, T., 2012. Pathoanatomy of cerebellar degeneration in
spinocerebellar ataxia type 2 (SCA2) and type 3 (SCA3). Cerebellum 11, 749–760.
Schmahmann, J.D., Pandya, D.N., 2008. Disconnection syndromes of basal ganglia, thala-
mus, and cerebrocerebellar systems. Cortex 44, 1037–1066.
Schmitz-Hübsch, T., DuMontcel, S.T., Baliko, L., Berciano, J., Boesch, S., Depondt, C., Giunti,
P., Globas, C., Infante, J., Kang, J.-S., 2006. Scale for the assessment and rating of ataxia
development of a new clinical scale. Neurology 66, 1717–1720.
Schulz, J.B., Borkert, J., Wolf, S., Schmitz-Hübsch, T., Rakowicz, M., Mariotti, C., Schoels, L.,
Timmann, D., van de Warrenburg, B., Dürr, A., 2010. Visualization, quantiﬁcation and
correlation of brain atrophy with clinical symptoms in spinocerebellar ataxia types 1,
3 and 6. NeuroImage 49, 158–168.
Solodkin, A., Peri, E., Chen, E.E., Ben-Jacob, E., Gomez, C.M., 2011. Loss of intrinsic organi-
zation of cerebellar networks in spinocerebellar ataxia type 1: correlates with disease
severity and duration. Cerebellum 10, 218–232.
Soong, B.-W., Lu, Y.-C., Choo, K.-B., Lee, H.-Y., 2001. Frequency analysis of autosomal dom-
inant cerebellar ataxias in Taiwanese patients and clinical and molecular characteri-
zation of spinocerebellar ataxia type 6. Arch. Neurol. 58, 1105–1109.
Stefanescu, M.R., Dohnalek, M., Maderwald, S., Thürling, M., Minnerop, M., Beck, A.,
Schlamann, M., Diedrichsen, J., Ladd, M.E., Timmann, D., 2015. Structural and func-
tional MRI abnormalities of cerebellar cortex and nuclei in SCA3, SCA6 and
Friedreich's ataxia. Brain 138, 1182–1197.
Takiyama, Y., Oyanagi, S., Kawashima, S., Sakamoto, H., Saito, K., Yoshida, M., Tsuji, S.,
Mizuno, Y., Nishizawa, M., 1994. A clinical and pathologic study of a large Japanese
family with Machado-Joseph disease tightly linked to the DNA markers on chromo-
some 14q. Neurology 44, 1302.
Thompson, P.M., Lee, A.D., Dutton, R.A., Geaga, J.A., Hayashi, K.M., Eckert, M.A., Bellugi, U.,
Galaburda, A.M., Korenberg, J.R., Mills, D.L., 2005. Abnormal cortical complexity and
thickness proﬁles mapped in Williams syndrome. J. Neurosci. 25, 4146–4158.
Wang, P.-S., Chen, H.-C., Wu, H.-M., Lirng, J.-F., Wu, Y.-T., Soong, B.-W., 2012. Association
between proton magnetic resonance spectroscopy measurements and CAG repeat
number in patients with spinocerebellar ataxias 2, 3, or 6. PLoS One 7, e47479.
Wang, Z., Dai, Z., Gong, G., Zhou, C., He, Y., 2014. Understanding structural-functional re-
lationships in the human brain a large-scale network perspective. Neuroscientist
1073858414537560.
Wang, T.-Y., Jao, C.-W., Soong, B.-W., Wu, H.-M., Shyu, K.-K., Wang, P.-S., Wu, Y.-T., 2015.
Change in the cortical complexity of spinocerebellar ataxia type 3 appears earlier
than clinical symptoms. PLoS One 10.
Wang, P.-S., Liu, R.-S., Yang, B.-H., Soong, B.-W., 2007. Regional patterns of cerebral glu-
cose metabolism in spinocerebellar ataxia type 2, 3 and 6. J. Neurol. 254, 838–845.
Wu, Y.-T., Shyu, K.-K., Jao, C.-W., Wang, Z.-Y., Soong, B.-W., Wu, H.-M., Wang, P.-S., 2010.
Fractal dimension analysis for quantifying cerebellar morphological change of multi-
ple system atrophy of the cerebellar type (MSA-C). NeuroImage 49, 539–551.
Wu, T., Wang, C., Wang, J., Hallett, M., Zang, Y., Chan, P., 2013. Preclinical and clinical neu-
ral network changes in SCA2 Parkinsonism. Parkinsonism Relat. Disord. 19, 158–164.
Yamada, M., Tan, C.F., Inenaga, C., Tsuji, S., Takahashi, H., 2004. Sharing of polyglutamine
localization by the neuronal nucleus and cytoplasm in CAG-repeat diseases.
Neuropathol. Appl. Neurobiol. 30, 665–675.
Zhou, J., Lei, L., Liao, X., Wang, J., Jiang, H., Tang, B., Shen, L., 2011. Related factors of ICARS
and SARA scores on spinocerebellar ataxia type 3/Machado-Joseph disease. Zhong
Nan Da Xue Xue Bao Yi Xue Ban 36, 498–503.
